Regulatory Filings

TSXHLS

Description	Date	Format
News release - English	Aug 16, 2021
News release - English	Aug 5, 2021
News release - English	Aug 4, 2021
News release - English	Jul 22, 2021
News release - English	Jun 18, 2021
News release - English	Jun 15, 2021
News release - English	Jun 9, 2021
News release - English	May 26, 2021
News release - English	May 6, 2021
News release - English	Apr 22, 2021
News release - English	Apr 15, 2021
News release - English	Apr 1, 2021
News release - English	Mar 29, 2021
News release - English	Mar 18, 2021
News release - English	Mar 17, 2021
News release - English	Mar 4, 2021
News release - English	Feb 23, 2021
News release - English	Feb 16, 2021
News release - English	Feb 16, 2021
News release - English	Jan 28, 2021
News release - English	Jan 4, 2021
News release - English	Dec 21, 2020
News release - English	Dec 16, 2020
News release - English	Dec 14, 2020
News release - English	Nov 19, 2020
1-25 26-32

SEDAR® is a registered trade-mark of and property of the Alberta Securities Commission

HLS Therapeutics Inc.

HLS provides access to
treatments critical to patients
and their caregivers with the
brand names they trust.

Site Menu

Contact Info

1-647-495-9000

10 Carlson Court, Suite 701
Etobicoke, Ontario, M9W 6L2

U.S. Privacy Policy | Canada Privacy Policy | Terms of Use

WS0004_0